A comprehensive intervention for preventing unintended pregnancies among teens led to greater use of long-acting reversible contraception, fewer incidences of unprotected sex, and a big reduction in unintended pregnancies, results of a new study revealed.
Cardiovascular disease among women of reproductive age has increased in recent years for a variety of reasons, and reproductive health providers should be aware of particular risk factors and issues involving this population. Clinicians should help this high-risk group prevent unplanned pregnancies, researchers noted.
Adolescents living with HIV in the United States are among the groups with the highest rates of adolescent pregnancy. The latest research shows these pregnancies are likely to be unintended. Researchers found 83.6% of pregnancies among HIV-infected adolescents were unintended. Among adult women with HIV in this study, 68.7% experienced unintended pregnancy.
An estimated 5% of women in jails are pregnant, and human rights groups and researchers have collected evidence that these women often receive poor care and are neglected. One solution is to provide contraceptive care to incarcerated women who would like to avoid pregnancy.
Stigma is a major barrier to women with substance use disorder receiving reproductive healthcare and contraceptives. Clinicians should ask women, including those with substance use disorder, about their goals, values, and what they find most important in contraception.
Drug delivery platform will release medication for monthly dosing
August 30, 2019
Although lowering side effects plays an important role in oral contraceptive compliance, one of the biggest challenges for patients is adhering to the daily schedule of the pill. Forgetting one to three pills per cycle is a frequent problem among 15-51% of users, particularly among adolescents. Lyndra Therapeutics has received a $13 million grant from the Bill & Melinda Gates Foundation and is setting out to remove the daily pill compliance challenge. The company is in early development of a monthly oral contraceptive to provide women with a discreet, noninvasive, reversible contraception option.
Despite guidance stating that a patient should be offered the option to begin her chosen long-acting reversible contraception birth control method at the time of the office visit rather than waiting for her next period or returning for another appointment, just 29% of clinicians say they provide same-day placement.
In 2002, just 2.4% of U.S. women using birth control were using long-acting reversible contraceptive (LARC) methods, such as the intrauterine device or the contraceptive implant. By 2014, about 14% of women using birth control reported LARC use.
Immediate postpartum placement offers safe, effective birth control
May 25, 2018
The American College of Obstetricians and Gynecologists now recognizes immediate postpartum placement of either the intrauterine device or the contraceptive implant as a best practice because of the long-acting reversible contraceptive methods’ role in preventing rapid repeat and unintended pregnancy